• Images
  • Videos
  • Vectors
  • Low Budget
  • Press

Stock Photo - J. Michael Pearson, Chief Executive Officer, Valeant Pharmaceuticals International, Inc; gives testimony before the United States Senate Committee on Aging hearing on _Valeant Pharmaceuticals' Business Model: the Repercussions for Patients and the Health Care System_ on Capitol Hill in Washington, DC on Wednesday, April 27, 2016. Valeant raised the price of four life-saving drugs: Isuprel by about 720 percent; Nitropress by 310 percent; Cuprimine by 5,878 percent, and Syprine by 3,162 percent after acquiring them in 2015. It is the high prices that are now at the heart of two congressional probes. Credit: Ron Sachs / CNP - NO WIRE SERVICE - | usage worldwide. - Washington/United States of America

Stock Photo: J. Michael Pearson, Chief Executive Officer, Valeant Pharmaceuticals International, Inc; gives testimony before the United States Senate Committee on Aging.

Royalty Free License

Choose the resolution that best suits your needs

Size pxcm ppi Price
XS 500 KB A10+ 342 x 512 px 72
S 2 MB A8+ 683 x 1023 px 300
M 10 MB A5 2002 x 3000 px 300
Available only for EDITORIAL USE
This image is not included in the easySUBSCRIPTIONS PLANS
Buy now
Add to cart
DELIVERY: Image compressed as JPG

Details

Image Code: PAH-67822251 User license: Rights Managed Shooting date: 4/27/2016 HI-RES availability: Up to M 10 MB A5 (2002 x 3000 px - 6.7" x 10" - 300 ppi)

Important Information

Releases: No signed releases for this image.

Availability: Image availability cannot be guaranteed until time of purchase.

Searchable keywords

Choose multiple keywords